In an adult patient with hidradenitis suppurativa and no known drug allergies, does trimethoprim‑sulfamethoxazole (Bactrim) provide therapeutic benefit?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Trimethoprim-Sulfamethoxazole (Bactrim) for Hidradenitis Suppurativa

Trimethoprim-sulfamethoxazole (Bactrim) is NOT recommended for hidradenitis suppurativa treatment based on the most recent 2026 AAD-HSF guidelines, which do not include it among the conditionally recommended systemic antibiotics for HS. 1

Guideline-Based Antibiotic Recommendations

The 2026 joint American Academy of Dermatology-Hidradenitis Suppurativa Foundation guidelines provide clear conditional recommendations for specific systemic antibiotics in HS 1:

Conditionally recommended antibiotics:

  • Doxycycline (very low certainty evidence)
  • Tetracycline (very low certainty evidence)
  • Clindamycin in combination with rifampin (very low certainty evidence)
  • Ertapenem for moderate to severe HS (very low certainty evidence)

Notably absent: Trimethoprim-sulfamethoxazole is conspicuously not mentioned in the guideline recommendations, despite the comprehensive scope covering all available systemic antibiotics in the United States 1.

The Antibiotic Resistance Problem

The omission of trimethoprim-sulfamethoxazole from guidelines is supported by concerning resistance data. Research demonstrates that patients taking trimethoprim/sulfamethoxazole were significantly more likely to grow trimethoprim/sulfamethoxazole-resistant Proteus species compared with patients using no antibiotics (88% vs 0%; P < .001) 2. This represents one of the highest rates of antibiotic resistance observed across all antibiotics studied in HS lesions.

Why Bactrim Is Not Appropriate for HS

The FDA-approved indications for Bactrim do not include hidradenitis suppurativa 3. Approved indications include urinary tract infections, acute otitis media, acute exacerbations of chronic bronchitis, shigellosis, Pneumocystis jirovecii pneumonia, and traveler's diarrhea—but not inflammatory skin conditions like HS 3.

The mechanism of action and antimicrobial spectrum of trimethoprim-sulfamethoxazole do not align with the pathophysiology of HS, which is primarily an immune-mediated inflammatory disease of the terminal hair follicle unit rather than a primary infectious process 4. While bacterial colonization occurs, it is secondary to the underlying inflammatory pathology.

Clinical Implications and Antibiotic Stewardship

Use the guideline-recommended antibiotics instead:

  • For mild to moderate HS: Start with doxycycline or tetracycline monotherapy
  • For more resistant or severe cases: Consider clindamycin plus rifampin combination
  • For moderate to severe HS with acute flares: Ertapenem may be appropriate

The high rate of antibiotic resistance development with trimethoprim-sulfamethoxazole in HS lesions 2 underscores the importance of antibiotic stewardship. Prescribing antibiotics not supported by guidelines increases the risk of developing drug-resistant bacteria without providing proven benefit 3, 2.

The Broader Treatment Context

Modern HS management recognizes that antibiotics serve primarily an anti-inflammatory role rather than antimicrobial function 5, 6. The most effective long-term management involves:

  • Biologic therapies (adalimumab, secukinumab, bimekizumab) for moderate to severe disease 1, 7
  • Antibiotics as bridge therapy or for acute flares 5
  • Procedural interventions for persistent lesions 1

Given that skin flora predominate in HS lesions (76.4% of cultures) rather than pathogenic bacteria 8, and that HS is fundamentally an inflammatory rather than infectious disease 4, the focus should be on immunomodulatory therapies rather than expanding antibiotic use to non-evidence-based agents like trimethoprim-sulfamethoxazole.

Related Questions

For a patient with hidradenitis suppurativa who has completed a 30‑day course of doxycycline 100 mg daily and daily benzoyl‑peroxide 5 % wash and now reports marked skin improvement, what is the recommended next step in management?
Is it appropriate to use amoxicillin‑clavulanate (co‑amoxiclav) for hidradenitis suppurativa?
Can I treat hidradenitis suppurativa with Kenalog (triamcinolone) injections?
Can naproxen 500 mg be used as maintenance therapy for hidradenitis suppurativa?
In a 54-year-old female with a right cheek abscess and a history of hidradenitis suppurativa (first facial lesion), what additional therapy besides doxycycline, such as ceftriaxone, should be considered to reduce swelling and pain?
Should oseltamivir (Tamiflu) be prescribed for a patient with suspected influenza?
What are the recommended treatments for weight loss in polycystic ovary syndrome (PCOS)?
How should I use the new PREVENT risk score alongside the traditional ASCVD (Atherosclerotic Cardiovascular Disease) risk estimator?
Does an adult patient with major depressive disorder, body‑dysmorphic disorder, an eating disorder, and a history of substance use who reports transient dissociative symptoms, impulsivity in multiple self‑damaging areas, affective instability, identity disturbance, and chronic emptiness meet DSM‑5 criteria for Borderline Personality Disorder?
What is the appropriate management of a popliteal synovial cyst in a 4-year-old child?
What are the recommended tips, tricks, and dosages for labor analgesia in a healthy term parturient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.